For his research on angiogenesis, the process of new blood vessel formation that plays a key role in cancer proliferation and a number of other diseases.
 Napoleone Ferrara, M.D.
Genentech Fellow, San Francisco, California, U.S.A.  Erik De Clercq, M.D., Ph.D.
Professor Emeritus, Rega Institute for Medical Research, Leuven, Belgium Anthony S. Fauci, M.D. For their pioneering work in understanding and combating viral diseases, particularly HIV/AIDS.  Axel Ullrich, Ph.D.
Director of the Department of Molecular Biology, Max Planck Institute of Biochemistry, Munich, Germany. For his pioneering work in applying molecular biology and molecular cloning to the discovery of protein therapeutics for the treatment of a wide range of diseases, including diabetes and cancer.  Marc Feldmann, FMedSci, FAA, FRS
Kennedy Institute of Rheumatology, Imperial College Sir Ravinder Maini, FMedSci, FRCP, FRS Kennedy Institute of Rheumatology, Imperial College For their role in the discovery of tumor necrosis factor-alpha as an effective therapeutic target for rheumatoid arthritis and other chronic inflammatory conditions. |
Nomination Form – Click here
Nominations will open on April 15, 2024 and close on June 7, 2024.
Please note: you must input the nominee’s CV and any optional recommendation letters to a zip file and email to ra-jjcus-pjaward@corus.jnj.com